About EarlySense
EarlySense is a company based in Woburn (United States) founded in 2004 by Avner Halperin. It operates as a B2B. EarlySense has raised $124 million across 7 funding rounds from investors including Mitsui & Co, Bank Hapoalim and Hill-Rom. EarlySense operates in a competitive market with competitors including ZOLL AEDs, Bardy Diagnostics, Cardiotrack, Avertix and Oxehealth, among others.
- Headquarter Woburn, United States
- Founders Avner Halperin
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$124 M (USD)
in 7 rounds
-
Latest Funding Round
$39 M (USD), Series H
Jan 07, 2019
-
Investors
Mitsui & Co.
& 17 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of EarlySense
Unlock access to complete
Unlock access to complete
Funding Insights of EarlySense
EarlySense has successfully raised a total of $124M across 7 strategic funding rounds. The most recent funding activity was a Series H round of $39 million completed in January 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in EarlySense
EarlySense has secured backing from 18 investors, including institutional and venture fund investors. Prominent investors backing the company include Mitsui & Co, Bank Hapoalim and Hill-Rom.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments in tech and healthtech sectors through dedicated funds.
|
Locked | Locked | Locked | |
|
Sector-agnostic VC firm investing in geographies such as the US
|
Locked | Locked | Locked | |
|
No specific activity is described for BlueRed Partners.
|
Locked | Locked | Locked |
Investor details for EarlySense
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by EarlySense
Investment portfolio details for EarlySense
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - EarlySense
Detailed financials for EarlySense
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Earlysense Comparisons
Peer comparison for EarlySense
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of EarlySense
EarlySense operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ZOLL AEDs, Bardy Diagnostics, Cardiotrack, Avertix and Oxehealth, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Medical devices and software for emergency care are developed.
|
|
| Locked | Locked | Locked |
Develops and markets the Carnation Ambulatory Monitor
|
|
| Locked | Locked | Locked |
AI-based EGC data capture and analysis platform
|
|
| Locked | Locked | Locked |
An implantable warning system for heart attack detection is provided.
|
|
| Locked | Locked | Locked |
Contactless patient monitoring is provided for mental health facilities.
|
Detailed competitors of EarlySense
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Earlysense
Complete news archive for EarlySense
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about EarlySense
EarlySense was founded in 2004 and raised its 1st funding round 6 years after it was founded.
EarlySense is headquartered in Woburn, United States. It is registered at Woburn, Massachusetts, United States.
Avner Halperin is the current CEO of EarlySense. They have also founded this company.
EarlySense is a funded company, having raised a total of $124M across 7 funding rounds to date.
EarlySense, founded in 2004 in Woburn, United States, focuses on providing healthcare solutions, developing medical devices, providing health monitoring, and cardiac technology. Develops innovative smart devices for cardiac health monitoring. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
EarlySense's top competitors include Oxehealth, ZOLL AEDs and Cardiotrack.
EarlySense has 18 investors. Key investors include Mitsui & Co, Bank Hapoalim, Hill-Rom, The Israel Innovation Fund, and Pitango.